Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... -- Ignore unavailable to you. Want to Upgrade?

To: Eagle who wrote (56651)	11/8/2006 11:20:45 AM
From: lexi2004	Respond to of 59879

LightPath Technologies First Quarter Fiscal Year 2007 Results Call scheduled for Wed, Nov 15 Vcall (Mon, Oct 23)

To: Eagle who wrote (56651)	11/9/2006 1:36:55 PM
From: hotlinktuna	Respond to of 59879

New IPO today, FACE in 19.35 a few minutes ago: Physicians Formula Holdings, Inc. Prices Initial Public Offering of Common Stock Wednesday November 8, 11:32 pm ET AZUSA, Calif., Nov. 8 /PRNewswire-FirstCall/ -- Physicians Formula Holdings, Inc. (Nasdaq: FACE - News) announced today the pricing of its initial public offering of 7,500,000 shares of its common stock at a price to the public of $17.00 per share. There are 4,375,000 shares being offered by selling stockholders and 3,125,000 shares being offered by Physicians Formula Holdings, Inc. (the "Company"). The net proceeds to the Company from this offering are intended to reduce the Company's outstanding indebtedness, to pay debt issuance costs and to pay IPO completion bonuses. The selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 1,125,000 shares at the initial public offering price to cover over-allotments, if any. ADVERTISEMENT The shares will trade on the Nasdaq Global Select Market under the symbol "FACE." The offering is being made through an underwriting syndicate led by Deutsche Bank Securities and Citigroup Corporate and Investment Banking as joint book-runners for the offering. Banc of America Securities LLC, Cowen and Company and Piper Jaffray are acting as co-managers. Copies of the final prospectus relating to the offering may be obtained from Deutsche Bank Securities Inc., c/o Prospectus Department, 60 Wall Street, Floor 2, New York, New York 10005 or by telephone toll free at 1-800-503-4611, fax: 212-468-5333 or from Citigroup Corporate and Investment Banking, Prospectus Department, Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York, 11220 (tel: 718-765-6732; fax: 718-765-6734). A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 8, 2006. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. (FACE/F) -------------------------------------------------------------------------------- Source: Physicians Formula Holdings, Inc.